ASTM E2524

ASTM E2524 is the ASTM standard for the Standard Test Method for Analysis of Hemolytic Properties of Nanoparticles, offering a focused framework for evaluating whether nanoparticle materials may cause red blood cell damage. This matters because hemolysis-related assessment is an important step in screening nanoparticle behavior for biomedical and related applications. By providing a consistent test method, the standard helps support clearer comparisons, better quality control, and more reliable product evaluation.

ASTM E2524 standard overview

This ASTM standard addresses the analysis of hemolytic properties in nanoparticles, which means it is centered on measuring how a nanoparticle sample interacts with blood components in a way that may lead to hemolysis. As a technical document, ASTM E2524 is useful for establishing a repeatable approach to testing and interpreting results in a controlled setting. It supports organizations that need a recognized method for assessing compatibility-related behavior during development, screening, or verification activities.

Where is ASTM E2524 used?

ASTM E2524 is commonly used in laboratory and product-development environments where nanoparticle materials are being evaluated for biological response. It is particularly relevant to workflows involving materials intended for contact with blood or other sensitive biological systems. The standard may also be used by testing labs, manufacturers, and quality teams that need a consistent method for comparing nanoparticle batches, confirming performance data, or supporting internal and external review of hemolysis-related results.

Practical importance of ASTM E2524

In practice, ASTM E2524 helps reduce uncertainty when assessing whether nanoparticles exhibit hemolytic behavior. A recognized test method can improve consistency across studies, support procurement decisions, and strengthen quality control documentation. It may also help teams compare materials more reliably and identify potential risks earlier in the development process. For organizations working with nanoparticle-based products, the standard provides a practical basis for more defensible testing and compliance-oriented evaluation.

• Hemolytic property analysis for nanoparticles
• Repeatable laboratory test method
• Support for quality control and comparison
• Useful for blood-contact evaluation workflows
• Technical reference for testing consistency